Feb 07, 2019
Myovant Provides Corporate Updates and Reports Financial Results for Third Fiscal Quarter Ended December 31, 2018
Nov 29, 2018
PMR Forecasts Untapped Growth Opportunity for Manufacturers of MRI Guided and Focused Ultrasound Devices
Nov 16, 2018
Women's Excellence in Rochester, Michigan Now Offers Treatment Plans for Women with Pelvic Pain
Oct 31, 2018
BioSpecifics Technologies Corp. Announces Positive Topline Results from Phase 1 Study of CCH for the Treatment of Uterine Fibroids
Oct 08, 2018
Global Uterine Fibroids Market and Competitive Landscape 2018: Pipeline, Epidemiology, Valuations, Product Sales, Market Forecast, Product Forecasts, and Market Shares
Oct 08, 2018
Myovant Sciences and Flo Health Partner to Develop Digital Tool to Screen Women for Heavy Menstrual Bleeding
Sep 13, 2018
Dr. James St. George, M.D. Launches Innovative New Fibroid Center in Jacksonville
Aug 22, 2018
AbbVie Announces Positive Topline Results from Phase 3 Extension Study Evaluating Investigational Elagolix in Women with Uterine Fibroids
Aug 21, 2018
Allergan Receives Complete Response Letter from the U.S. Food and Drug Administration for Ulipristal Acetate New Drug Application
Aug 09, 2018
BioSpecifics Technologies Corp. Reports Second Quarter 2018 Financial Results
Aug 07, 2018
Myovant Provides Corporate Update and Reports Financial Results for First Fiscal Quarter Ended June 30, 2018
Jul 10, 2018
Myovant Sciences Announces Completion of Screening for Phase 3 LIBERTY 1 Study Evaluating Relugolix in Women with Uterine Fibroids
May 09, 2018
BioSpecifics Technologies Corp. Reports First Quarter 2018 Financial Results
May 02, 2018
Women's Excellence Introduces Online Symptom Checker
Apr 27, 2018
AbbVie Presents New Investigational Data for Elagolix at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting
Apr 26, 2018
Allergan to Present New Data at the American College of Obstetrics and Gynecology 67th Annual Clinical and Scientific Meeting 2018
Mar 15, 2018
Information Update - Health Canada to conduct review of a new potential safety risk of Fibristal (ulipristal acetate), a medication used to treat fibroids
Mar 14, 2018
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 13, 2018
AbbVie Announces Positive Topline Results from Second Phase 3 Study Evaluating Investigational Elagolix in Women with Uterine Fibroids
Mar 12, 2018
BioSpecifics Technologies Corp. Announces Presentation of Interim Data from Phase 1 Study of CCH for the Treatment of Uterine Fibroids at 65th Annual Scientific Meeting of the Society for Reproductive Investigation